Navigation Links
HeartWare to Webcast Annual Meeting
Date:7/29/2009

FRAMINGHAM, Mass. and SYDNEY, July 29 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that its Annual Meeting will be held at The Westin Sydney, 1 Martin Place, Sydney at 7:00 pm US Eastern today, July 29 (9:00 am Sydney time on July 30, 2009).

The Annual Meeting will be webcast and may be viewed at the Company's website (www.heartware.com) by selecting "HeartWare International Annual General Meeting - Webcast" under the section titled Corporate Presentations (on the HOME page).

About HeartWare International, Inc.

HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or Left Ventricular Assist Devices (LVADs), to treat patients suffering from advanced heart failure. The HeartWare((R)) Ventricular Assist System features the HVAD((TM)) pump, the only full-output pump designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has completed an international clinical trial for the device involving five investigational centres in Europe and Australia. The device is currently the subject of a 150-patient clinical trial in the United States for a Bridge-to-Transplant indication. 

    For further information:
    US Investor Relations
    Matt Clawson
    Partner
    Allen & Caron Inc
    Email: matt@allencaron.com
    Tel: +1 949 474 4300


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. HeartWare to Present at Eighth Annual JMP Securities Research Conference
2. Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
3. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
4. HeartWare to Present at Seventh Annual JMP Securities Research Conference
5. HeartWare Receives Conditional Approval of IDE
6. HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility
7. HeartWare Selects Allen & Caron for Investor Relations and Corporate Communications
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
9. Medivation Announces Second Quarter 2009 Financial Results Teleconference and Webcast on August 5, 2009
10. FRC Action to Host Webcast Tonight on the Government Takeover of Health Care
11. FRC Action to Host Webcast on the Government Takeover of Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... York (PRWEB) May 25, 2013 Pradaxa ... suffered serious, life-threatening episodes of internal bleeding while using the ... in U.S. District Court, Southern District of Illinois, Bernstein Liebhard ... website, 818 Pradaxa side effect claims had been ... That’s up from 705 claims reported by the Court on ...
(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 ... dedicated to brain cancer research and advocacy, comments on ... Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into ... cells. , According to a Science Daily ... Extraterrestrial Physics (MPE), biologists and physicians demonstrated the “synergistic ...
(Date:5/25/2013)... 25, 2013 Dr. Farooq Ashraf, founder ... in Dubai, has announced his practice’s adoption of The ... only FDA-cleared femtosecond laser proven with more than 10 ... precision of LASIK. , “We are happy to announce ... Laser at our Dubai LASIK practice,” Ashraf said Thursday. ...
(Date:5/25/2013)... 2013 The Slim Weight Patch has been ... This is due to the highly sought after ingredients that ... patch offers an extra 2 months supply & premium membership ... get the body you desire faster than ever. , ... , With Slim weight patch consumers can observe instant results ...
(Date:5/25/2013)... Texas (PRWEB) May 25, 2013 ... stressful than finals week. Increasingly, they are turning ... stay awake and study. For more on this, ... a drug treatment facility, warns that students who ... finals” are at risk for developing a physical ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2Health News:Slim Weight Patch Advanced Weight Loss System Offers Extra Two Month Supply and Membership for Maximum Weight Loss 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2
... (NYSE: SCI ) announced it expects to issue a press release ... 2009, after the market closes. A conference call will be hosted ... conference call are as follows: , , ... Conference Call, ...
... ... , ... 2, 2009 -- Life Care Centers of America recently named Michael Lops as ... Life Care, succeeds Sharon Coleman in the position. His appointment is based on “his extensive ...
... visit questionnaire led to screening in high-risk study patients ... questionnaire can identify patients at high risk for lung ... in 2001 with 1,000 people in Colorado who were ... patients were asked to complete a five-minute questionnaire that ...
... ... become a certifying body upon the release of the Office of the National Coordinator for ... Group has been approached recently by numerous EHR software and services companies that need to ... Fort Worth, ...
... Nov. 2 What do sipping cocoa, snuggling under blankets ... more common during the cold winter months. , According ... 1,200 Americans die annually from a heart attack or similar ... is often the trigger. To help create awareness, work to ...
... 2 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the "Company") (Nasdaq: ... develops, manufactures and markets advanced in-vitro diagnostic,products, today announced ... second fiscal quarter ended September 30, 2009 ("2Q FY2009") ... The Company,s 2009 fiscal year,ends on March 31, 2010. ...
Cached Medicine News:Health News:Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call 2Health News:Lops named Life Care's New Chief Compliance Officer 2Health News:Drummond Group Plans to Certify Electronic Health Records 2Health News:Drummond Group Plans to Certify Electronic Health Records 3Health News:MTD Joins Forces with the AHA to Promote Heart Health 2Health News:China Medical Technologies to Announce Unaudited Financial Results for the Second Fiscal Quarter Ended September 30, 2009 on November 19, 2009 2
(Date:5/24/2013)... -- The potential of the pulmonary route ... agents has been receiving undeniable attention with the recent ... The crucial formulation considerations for orally inhaled products together ... role in the efficiency of pulmonary delivery, and great ... formulation techniques and devices in recent years. ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... 18, 2012 UCB, Inc., a leading biopharmaceutical company ... severe central nervous system and immunological disorders, is marking ... reinforcing its commitment to improving the lives of patients ... this year,s DDW meeting. "DDW is ...
... The new arthroscopy simulator ArthroS trains orthopedic surgeons for ... The Swiss company VirtaMed AG is launching ArthroS™, a ... get the chance to practice different operations numerous times ... as pilots improve their skills on flight simulators. ArthroS™ ...
Cached Medicine Technology:UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 2UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 3UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 4Swiss Engineering for Surgical Perfection 2Swiss Engineering for Surgical Perfection 3
... a new standard in QPCR with the ... system offers superior performance, more flexibility, and ... system - with Windows 98SE and Pentium ... Premier Sound Speakers, Surge Protector (US only), ...
... The LightCycler System is the ... The LightCycler System enables you to ... 30 min, and simultaneously quantify and ... during amplification. The unique Melting Curve ...
... ABI PRISM 7900HT Sequence Detection System ... that detects and quantitates nucleic acid ... 384-well plate capability make the 7900HT ... high-throughput requirements of todays drug discovery ...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Medicine Products: